Stock Issuance and Offering Costs, Explained: Why Your IPO Fees Reduce Paid-In Capital Instead of Hitting Your P&L

You close a $10 million funding round and watch roughly $800,000 of it vanish into underwriter spreads, legal bills, and accounting fees — then your accountant tells you the income statement shows $0 of expense. Nothing is wrong with your books. Under U.S. GAAP, the costs of issuing your own stock bypass the P&L entirely and shrink equity directly, while the costs of issuing debt take a completely different path onto the balance sheet. Book either one on the wrong track and you will misstate equity, misreport interest expense, and hand your auditors a restatement on your first serious financing.

This guide covers what counts as an offering cost, the rule that keeps equity issuance costs out of earnings, the journal entries that record them, why debt issuance costs work differently, the tax treatment of both, and the mistakes that most often trip up first-time issuers.

What counts as an offering cost​

Offering costs are the expenditures you incur to put securities into investors' hands. For a stock offering, the list typically includes:

• The underwriting spread (gross spread). The difference between what the underwriters pay you for the shares and what they sell them for to the public — the bank's compensation. For U.S. IPOs it clusters famously at 7% of gross proceeds: more than 93% of IPOs raising between $30 million and $160 million from 2001 through 2025 carried a spread of exactly 7.0%, and the 2025 median across all IPOs was 7.0%.
• Legal fees for the offering — securities counsel, blue-sky review, closing opinions.
• Accounting fees tied to the deal, including auditor comfort letters and consents.
• Printing the prospectus and registration statement.
• Registration, filing, and listing fees — SEC registration, FINRA filing, and the exchange listing fee.
• Transfer agent, registrar, and trustee fees, and for a bond offering, the initial credit rating agency fees.

These costs are large enough to matter structurally: total issuance costs average roughly 9% of gross proceeds for a company going public, which is one reason smaller companies often cannot afford a traditional IPO at all. A direct listing or a smaller private round changes the mix — no underwriter spread, for example — but the accounting question is the same either way: where do these costs land?

The core rule for equity: costs reduce paid-in capital, never earnings​

The governing guidance is SAB Topic 5.A, codified at ASC 340-10-S99-1: "specific incremental costs directly attributable to a proposed or actual offering of securities may properly be deferred and charged against the gross proceeds of the offering." In practice that means:

1. While the offering is still pending, you park qualifying costs on the balance sheet as a deferred charge (often labeled deferred offering costs).
2. When the offering closes, you net those costs against the proceeds — recorded as a reduction of additional paid-in capital (APIC), not as an expense.

So a company issuing 1,000,000 shares at $10.00 does not record $10 million of APIC (plus par) and $800,000 of expense. It records $9.2 million of net APIC. The income statement never sees the $800,000.

The logic is that issuing your own stock is a transaction with owners acting as owners — a capital transaction, not an operating event. GAAP keeps owner transactions in equity and out of net income, the same reason dividends are not an expense and stock buybacks do not create a loss. The offering costs are simply the friction on that capital transaction, so they reduce the capital raised rather than the period's earnings.

Note the two qualifiers doing the heavy lifting in "specific incremental costs directly attributable": the cost must be incremental (you would not have incurred it without the offering) and directly attributable to the offering. That test is where most errors live, as the mistakes section below shows.

The journal entries, step by step​

Suppose your company issues 1,000,000 shares of $0.10 par common stock at $10.00 per share — $10 million gross. The underwriters take a 7% spread ($700,000), and you have already paid $120,000 in legal and accounting bills that you deferred while the deal was pending.

Step 1: Defer the pre-closing costs. When each bill arrives before the offering closes:

• Debit Deferred offering costs (asset): $120,000
• Credit Cash: $120,000

Step 2: Record the closing, net of everything. Cash in is $9.3 million ($10 million minus the $700,000 spread the underwriters keep). Common stock gets par value of $100,000. APIC gets the rest — gross proceeds minus par, minus the spread, minus the deferred costs:

• Debit Cash: $9,300,000
• Debit APIC (offering costs: $700,000 spread + $120,000 deferred): $820,000
• Credit Deferred offering costs (clearing it): $120,000
• Credit Common stock (par): $100,000
• Credit APIC (gross excess over par): $9,900,000

Debits and credits both total $10,120,000, net APIC is $9,080,000, and no expense account is touched at any point.

If you keep your books in plain text, the same two steps look like this — note how the deferred-costs asset clears through the equity postings at close, with no expense leg anywhere:

2026-01-10 * "Legal retainer for offering - deferred until close"
  Assets:Deferred-Offering-Costs   120,000.00 USD
  Assets:Checking:Operating       -120,000.00 USD
 
2026-03-15 * "Issue 1,000,000 shares at $10.00, $700,000 underwriter spread"
  Assets:Checking:Operating           9,300,000.00 USD
  Assets:Deferred-Offering-Costs       -120,000.00 USD
  Equity:Common-Stock                  -100,000.00 USD
  Equity:Additional-Paid-In-Capital  -9,080,000.00 USD

See the Beancount syntax documentation if the negative-sign convention for equity postings is new to you — the signs simply record which side of the ledger each leg falls on.

Debt issuance costs work completely differently​

Everything above applies to equity. The costs of issuing debt — the same kinds of line items: legal fees, arrangement fees, printing, rating agency fees — follow ASC 835 instead, and the treatment changed materially in 2015 with ASU 2015-03:

• Presentation: debt issuance costs are reported as a direct deduction from the carrying amount of the debt on the balance sheet, the same way a bond discount is presented. They are not a standalone deferred-charge asset. A $5 million note with $100,000 of unamortized issuance costs shows as a $4.9 million liability.
• Amortization: the costs are amortized to interest expense over the life of the debt, generally using the effective interest method — again, exactly like a discount. So unlike equity costs, debt costs do reach the income statement, gradually, as part of borrowing cost.
• The revolver exception: fees paid for a revolving line of credit (where no loan is drawn yet) may still be carried as an asset and amortized over the facility term, per the follow-up guidance in ASU 2015-15 — there is no debt balance to deduct them from until you borrow.

The contrast is worth memorizing as a pair:

That table also explains the most expensive classification error in this area: in a combined offering (say, convertible notes with detachable warrants), the issuance costs must be allocated between the debt and equity components in proportion to the proceeds assigned to each — the debt slice amortizes into interest, the equity slice reduces APIC, and stuffing all of it down one track misstates both.

The tax side: stock costs are nondeductible, debt costs amortize​

Book and tax agree on the mechanics but diverge on timing and deductibility:

• Stock issuance costs are not deductible, ever. The IRS position, restated in internal memorandum AM 2020-003, is that these costs are capitalized by netting against the sale proceeds — there is no separate asset to amortize, and no deduction when the company later goes private or the stock is otherwise retired. Commissions and offering fees simply reduce the amount realized, permanently.
• Abandoned offerings are the one exception. If the issuance never happens, the costs you deferred have nothing to net against — GAAP expenses them, and for tax they become a Section 165 loss in the year the transaction is abandoned. This is the only path by which offering costs become deductible, and it requires a genuinely dead deal, not a postponed one.
• Debt issuance costs are amortizable for tax, generally ratably over the term of the loan — close to the book treatment, though computed under tax rules rather than the effective interest method.

The practical consequence: a profitable company closing an equity round gets no tax shield from its offering costs, while the same dollars spent issuing bonds would amortize into deductible interest. That asymmetry is real, but it should never drive the financing choice by itself — it is one input among cost of capital, dilution, and covenant risk.

Five mistakes first-time issuers make​

1. Expensing the IPO legal bills. The instinct to debit Legal expense for every lawyer invoice is strong, and it is wrong for offering work. If the invoice says the work served the offering, defer it (pre-close) or net it against APIC (at close). Auditors test this classification on every first-time issuer.

2. Netting costs that are not incremental. General overhead, management salaries during the offering period, and the audit fees you would have paid anyway do not qualify — SAB Topic 5.A covers only costs you would not have incurred without the offering. Sweeping ordinary expenses into APIC inflates earnings and is exactly the kind of restatement that follows a sloppy IPO close.

3. Still booking debt fees as a deferred asset. Pre-2015 GAAP allowed debt issuance costs as an asset; ASU 2015-03 ended that for term debt a decade ago. If your chart of accounts still carries a "deferred financing fees" asset against a term loan, reclassify it against the liability — covenant ratios computed on reported debt can shift when you do.

4. Leaving deferred costs on the books after the deal dies. An abandoned offering means the deferred-cost asset is worthless: write it off to expense immediately. Stale deferred offering costs from a deal that quietly died two quarters ago are a classic audit adjustment.

5. Forgetting to allocate in mixed offerings. Convertible debt, units of stock plus warrants, simultaneous debt-and-equity raises — whenever one set of invoices serves two kinds of securities, allocate the costs between the APIC track and the debt-discount track on a reasonable, documented basis (usually relative proceeds). One-track booking overstates either equity or future interest expense.

Your pre-close checklist​

Before the closing wire moves, confirm four things: every offering invoice is coded to the deferred-costs asset rather than an expense account; each coded cost passes the incremental-and-directly-attributable test; the debt-versus-equity split is documented if the offering mixes security types; and your tax provision reflects that the equity slice buys no deduction. Get those four right and the closing entry is arithmetic — gross proceeds in, par and net APIC out, and an income statement that correctly shows nothing at all.